Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and presence of the M1-receptor antagonist telenzepine

S. Teyssen, E. Niebergall, Suresh T Chari, M. V. Singer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To answer the questions if the type of continuous dose-response technique influences the pancreatic secretory response to intraduodenal tryptophan and if the M1-receptor antagonist telenzepine influences the intestinal absorption of tryptophan, we determined, in 12 conscious dogs with chronic gastric and duodenal fistulas, pancreatic bicarbonate and protein secretion and tryptophan plasma concentrations following intraduodenal tryptophan perfusion using two dose-response techniques. With an ascending continuous dose-response technique (aDRT), tryptophan was perfused in loads ranging from 0.12 to 10.0 mmol h-1, starting with the lowest load and tripling it every 45 min. With the descending continuous dose-response technique (dDRT), the order of tryptophan loads was reversed, with the highest load being given first. All studies were done on a fixed background of intravenous secretin (20.5 pmol kg-1 h-1 and repeated in the presence of the anticholinergic M1-receptor antagonist telenzepine (243 nmol kg-1 h-1). The bicarbonate and protein response as well as the tryptophan plasma concentrations to the same loads of tryptophan did not differ significantly between the two techniques. Using both techniques, telenzepine significantly (p < 0.05) inhibited the overall pancreatic protein response by 65% (dDRT) to 81% (aDRT). The overall bicarbonate response was only numerically, and not statistically significantly, inhibited by telenzepine. Tryptophan plasma concentrations after duodenal perfusion with tryptophan were neither influenced by the order of tryptophan loads nor altered by telenzepine. These findings indicate that in the intact animal (a) either the aDRT or the dDRT may be used to study the pancreatic secretory response to enteral infusion of amino acids, (b) at least part of the pancreatic secretory response to tryptophan is mediated through cholinergic M1 receptors, and (c) the duodenal absorption of tryptophan is not affected by telenzepine and therefore most likely not mediated by neuronal M1 receptors.

Original languageEnglish (US)
Pages (from-to)368-373
Number of pages6
JournalPancreas
Volume10
Issue number4
StatePublished - 1995
Externally publishedYes

Fingerprint

Tryptophan
Bicarbonates
telenzepine
Perfusion
Gastric Fistula
Proteins
Secretin
Intestinal Absorption
Cholinergic Antagonists
Cholinergic Receptors
Small Intestine
Dogs
Amino Acids

Keywords

  • Dose- response techniques
  • Pancreatic bicarbonate
  • Protein secretion
  • Telenzepine
  • Tryptophan

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and presence of the M1-receptor antagonist telenzepine. / Teyssen, S.; Niebergall, E.; Chari, Suresh T; Singer, M. V.

In: Pancreas, Vol. 10, No. 4, 1995, p. 368-373.

Research output: Contribution to journalArticle

@article{8bd96f618bba4e3eacf964a3feabfb74,
title = "Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and presence of the M1-receptor antagonist telenzepine",
abstract = "To answer the questions if the type of continuous dose-response technique influences the pancreatic secretory response to intraduodenal tryptophan and if the M1-receptor antagonist telenzepine influences the intestinal absorption of tryptophan, we determined, in 12 conscious dogs with chronic gastric and duodenal fistulas, pancreatic bicarbonate and protein secretion and tryptophan plasma concentrations following intraduodenal tryptophan perfusion using two dose-response techniques. With an ascending continuous dose-response technique (aDRT), tryptophan was perfused in loads ranging from 0.12 to 10.0 mmol h-1, starting with the lowest load and tripling it every 45 min. With the descending continuous dose-response technique (dDRT), the order of tryptophan loads was reversed, with the highest load being given first. All studies were done on a fixed background of intravenous secretin (20.5 pmol kg-1 h-1 and repeated in the presence of the anticholinergic M1-receptor antagonist telenzepine (243 nmol kg-1 h-1). The bicarbonate and protein response as well as the tryptophan plasma concentrations to the same loads of tryptophan did not differ significantly between the two techniques. Using both techniques, telenzepine significantly (p < 0.05) inhibited the overall pancreatic protein response by 65{\%} (dDRT) to 81{\%} (aDRT). The overall bicarbonate response was only numerically, and not statistically significantly, inhibited by telenzepine. Tryptophan plasma concentrations after duodenal perfusion with tryptophan were neither influenced by the order of tryptophan loads nor altered by telenzepine. These findings indicate that in the intact animal (a) either the aDRT or the dDRT may be used to study the pancreatic secretory response to enteral infusion of amino acids, (b) at least part of the pancreatic secretory response to tryptophan is mediated through cholinergic M1 receptors, and (c) the duodenal absorption of tryptophan is not affected by telenzepine and therefore most likely not mediated by neuronal M1 receptors.",
keywords = "Dose- response techniques, Pancreatic bicarbonate, Protein secretion, Telenzepine, Tryptophan",
author = "S. Teyssen and E. Niebergall and Chari, {Suresh T} and Singer, {M. V.}",
year = "1995",
language = "English (US)",
volume = "10",
pages = "368--373",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Comparison of two dose-response techniques to study the pancreatic secretory response to intraduodenal tryptophan in the absence and presence of the M1-receptor antagonist telenzepine

AU - Teyssen, S.

AU - Niebergall, E.

AU - Chari, Suresh T

AU - Singer, M. V.

PY - 1995

Y1 - 1995

N2 - To answer the questions if the type of continuous dose-response technique influences the pancreatic secretory response to intraduodenal tryptophan and if the M1-receptor antagonist telenzepine influences the intestinal absorption of tryptophan, we determined, in 12 conscious dogs with chronic gastric and duodenal fistulas, pancreatic bicarbonate and protein secretion and tryptophan plasma concentrations following intraduodenal tryptophan perfusion using two dose-response techniques. With an ascending continuous dose-response technique (aDRT), tryptophan was perfused in loads ranging from 0.12 to 10.0 mmol h-1, starting with the lowest load and tripling it every 45 min. With the descending continuous dose-response technique (dDRT), the order of tryptophan loads was reversed, with the highest load being given first. All studies were done on a fixed background of intravenous secretin (20.5 pmol kg-1 h-1 and repeated in the presence of the anticholinergic M1-receptor antagonist telenzepine (243 nmol kg-1 h-1). The bicarbonate and protein response as well as the tryptophan plasma concentrations to the same loads of tryptophan did not differ significantly between the two techniques. Using both techniques, telenzepine significantly (p < 0.05) inhibited the overall pancreatic protein response by 65% (dDRT) to 81% (aDRT). The overall bicarbonate response was only numerically, and not statistically significantly, inhibited by telenzepine. Tryptophan plasma concentrations after duodenal perfusion with tryptophan were neither influenced by the order of tryptophan loads nor altered by telenzepine. These findings indicate that in the intact animal (a) either the aDRT or the dDRT may be used to study the pancreatic secretory response to enteral infusion of amino acids, (b) at least part of the pancreatic secretory response to tryptophan is mediated through cholinergic M1 receptors, and (c) the duodenal absorption of tryptophan is not affected by telenzepine and therefore most likely not mediated by neuronal M1 receptors.

AB - To answer the questions if the type of continuous dose-response technique influences the pancreatic secretory response to intraduodenal tryptophan and if the M1-receptor antagonist telenzepine influences the intestinal absorption of tryptophan, we determined, in 12 conscious dogs with chronic gastric and duodenal fistulas, pancreatic bicarbonate and protein secretion and tryptophan plasma concentrations following intraduodenal tryptophan perfusion using two dose-response techniques. With an ascending continuous dose-response technique (aDRT), tryptophan was perfused in loads ranging from 0.12 to 10.0 mmol h-1, starting with the lowest load and tripling it every 45 min. With the descending continuous dose-response technique (dDRT), the order of tryptophan loads was reversed, with the highest load being given first. All studies were done on a fixed background of intravenous secretin (20.5 pmol kg-1 h-1 and repeated in the presence of the anticholinergic M1-receptor antagonist telenzepine (243 nmol kg-1 h-1). The bicarbonate and protein response as well as the tryptophan plasma concentrations to the same loads of tryptophan did not differ significantly between the two techniques. Using both techniques, telenzepine significantly (p < 0.05) inhibited the overall pancreatic protein response by 65% (dDRT) to 81% (aDRT). The overall bicarbonate response was only numerically, and not statistically significantly, inhibited by telenzepine. Tryptophan plasma concentrations after duodenal perfusion with tryptophan were neither influenced by the order of tryptophan loads nor altered by telenzepine. These findings indicate that in the intact animal (a) either the aDRT or the dDRT may be used to study the pancreatic secretory response to enteral infusion of amino acids, (b) at least part of the pancreatic secretory response to tryptophan is mediated through cholinergic M1 receptors, and (c) the duodenal absorption of tryptophan is not affected by telenzepine and therefore most likely not mediated by neuronal M1 receptors.

KW - Dose- response techniques

KW - Pancreatic bicarbonate

KW - Protein secretion

KW - Telenzepine

KW - Tryptophan

UR - http://www.scopus.com/inward/record.url?scp=0028927722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028927722&partnerID=8YFLogxK

M3 - Article

C2 - 7792293

AN - SCOPUS:0028927722

VL - 10

SP - 368

EP - 373

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -